Flosonics Medical, a Canadian medical device company focused on non-invasive hemodynamic monitoring, announced the close of a $14 million USD funding round led by Arboretum Ventures. The financing also included participation from existing investors iGan Partners and Genesys Capital. Dan Kidle, Partner at Arboretum Ventures, will join the board of directors.
Flosonics Medical is developing non-invasive wireless sensors to improve the management of critically ill patients. The company’s core technology, FloPatch, is a low cost, easy-to-use, wearable Doppler ultrasound sensor that adheres to a patient’s neck. FloPatch provides hands-free blood flow assessments during clinical interventions by sending data wirelessly to mobile devices using low energy Bluetooth.